411 related articles for article (PubMed ID: 20572907)
1. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
Kiriyama T; Kataoka H; Taoka T; Tonomura Y; Terashima M; Morikawa M; Tanizawa E; Kawahara M; Furiya Y; Sugie K; Kichikawa K; Ueno S
J Neuroimaging; 2011 Apr; 21(2):e69-77. PubMed ID: 20572907
[TBL] [Abstract][Full Text] [Related]
2. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Saini J; Chatterjee S; Thomas B; Kesavadas C
Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
[TBL] [Abstract][Full Text] [Related]
3. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
[TBL] [Abstract][Full Text] [Related]
4. Uncovering and characterizing multiple sclerosis lesions: the aid of fluid-attenuated inversion recovery images in the presence of gadolinium contrast agent.
Bagnato F
J Neuroimaging; 2009 Jul; 19(3):201-4. PubMed ID: 19187471
[No Abstract] [Full Text] [Related]
5. Tumefactive demyelinating lesions: a clinicopathological correlative study.
Neelima R; Krishnakumar K; Nair MD; Kesavadas C; Hingwala DR; Radhakrishnan VV; Nair SS
Indian J Pathol Microbiol; 2012; 55(4):496-500. PubMed ID: 23455787
[TBL] [Abstract][Full Text] [Related]
6. [A case of 53-years-old woman with the onset of subacute right-sided numbness, and presented with various lesions on MRI].
Mizoi Y; Ida M; Takao M; Koto A; Orimo S; Inoue K; Yokochi M; Kawamura M; Takagi M; Fukuda T; Fujigasaki J
No To Shinkei; 2005 Apr; 57(4):333-48. PubMed ID: 15948406
[No Abstract] [Full Text] [Related]
7. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
[TBL] [Abstract][Full Text] [Related]
8. Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.
Malhotra HS; Jain KK; Agarwal A; Singh MK; Yadav SK; Husain M; Krishnani N; Gupta RK
Mult Scler; 2009 Feb; 15(2):193-203. PubMed ID: 19181773
[TBL] [Abstract][Full Text] [Related]
9. Tumour-like lesions in multiple sclerosis.
Jamroz-Wiśniewska A; Janczarek M; Belniak E; Stelmasiak Z; Bartosik-Psujek H
Neurol Neurochir Pol; 2008; 42(2):161-7. PubMed ID: 18512174
[TBL] [Abstract][Full Text] [Related]
10. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.
Altintas A; Petek B; Isik N; Terzi M; Bolukbasi F; Tavsanli M; Saip S; Boz C; Aydin T; Arici-Duz O; Ozer F; Siva A
Mult Scler; 2012 Oct; 18(10):1448-53. PubMed ID: 22419670
[TBL] [Abstract][Full Text] [Related]
11. Tumefactive demyelinating lesions.
Dagher AP; Smirniotopoulos J
Neuroradiology; 1996 Aug; 38(6):560-5. PubMed ID: 8880719
[TBL] [Abstract][Full Text] [Related]
12. Role of perfusion magnetic resonance imaging in cervical lymphadenopathy.
Abdel Razek AA; Gaballa G
J Comput Assist Tomogr; 2011; 35(1):21-5. PubMed ID: 21245685
[TBL] [Abstract][Full Text] [Related]
13. Fat-saturated post gadolinium T1 imaging of the brain in multiple sclerosis.
Al-Saeed O; Ismail M; Athyal R; Sheikh M
Acta Radiol; 2011 Jun; 52(5):570-4. PubMed ID: 21498296
[TBL] [Abstract][Full Text] [Related]
14. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis.
Tan HM; Chan LL; Chuah KL; Goh NS; Tang KK
Br J Radiol; 2004 Feb; 77(914):153-6. PubMed ID: 15010391
[TBL] [Abstract][Full Text] [Related]
15. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging.
De Stefano N; Caramanos Z; Preul MC; Francis G; Antel JP; Arnold DL
Ann Neurol; 1998 Aug; 44(2):273-8. PubMed ID: 9708554
[TBL] [Abstract][Full Text] [Related]
16. [Neuroimaging in multiple sclerosis].
Rivera VM
Rev Neurol; 2001 Feb 1-15; 32(3):283-5. PubMed ID: 11310287
[TBL] [Abstract][Full Text] [Related]
17. Acute demyelinating disorder appearing as multiple cystic brain lesions.
Kim P; McDougall A
Arch Neurol; 2004 Jun; 61(6):966-7. PubMed ID: 15210542
[No Abstract] [Full Text] [Related]
18. DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem glioma.
Giussani C; Poliakov A; Ferri RT; Plawner LL; Browd SR; Shaw DW; Filardi TZ; Hoeppner C; Geyer JR; Olson JM; Douglas JG; Villavicencio EH; Ellenbogen RG; Ojemann JG
Neuroimage; 2010 Aug; 52(1):217-23. PubMed ID: 20363335
[TBL] [Abstract][Full Text] [Related]
19. Dominant perivenular enhancement of tumefactive demyelinating lesions in multiple sclerosis.
Zhang Y; Metz LM
Neurology; 2010 Oct; 75(15):1396. PubMed ID: 20938034
[No Abstract] [Full Text] [Related]
20. [A case of pediatric multiple sclerosis presenting with a tumefactive demyelinating lesion].
Majima H; Ito T; Koyama N
Rinsho Shinkeigaku; 2017 Feb; 57(2):88-91. PubMed ID: 28132974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
